BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burchardt E, Roszak A. Hyperthermia in cervical cancer - current status. Rep Pract Oncol Radiother 2018;23:595-603. [PMID: 30534024 DOI: 10.1016/j.rpor.2018.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Espenel S, Achkar S, Leary A, Gouy S, Chargari C. Combined modality including novel sensitizers in gynecological cancers. Int J Gynecol Cancer 2022;32:389-401. [DOI: 10.1136/ijgc-2021-002529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Fiorentini G, Sarti D, Gadaleta CD, Ballerini M, Fiorentini C, Garfagno T, Ranieri G, Guadagni S. A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019. Integr Cancer Ther 2020;19:1534735420932648. [PMID: 33054425 DOI: 10.1177/1534735420932648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
3 Mkrtchian L, Zamulaeva I, Krikunova L, Kiseleva V, Matchuk O, Liubina L, Kulieva G, Ivanov S, Kaprin A. HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer. J Pers Med 2021;11:479. [PMID: 34071821 DOI: 10.3390/jpm11060479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 IJff M, van Bochove GGW, Whitton D, Winiarczyk R, Honhoff C, Rodermond H, Crezee J, Stalpers LJA, Franken NAP, Oei AL. PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation. Cancers (Basel) 2021;13:2092. [PMID: 33926008 DOI: 10.3390/cancers13092092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Suresh RR, Baabu PRS, Rayappan JBB, Jbb AJ. Other Biosensors for Cervical Cancer Detection. Biomarkers and Biosensors for Cervical Cancer Diagnosis 2021. [DOI: 10.1007/978-981-16-2586-2_7] [Reference Citation Analysis]
6 Männle H, Stegmaier P, Münstedt K, Micke O. Zervixkarzinom – komplementäre und alternative Medizin (KAM) bei der Strahlentherapie des Beckens. Onkologe 2020;26:635-641. [DOI: 10.1007/s00761-020-00781-y] [Reference Citation Analysis]
7 Chang S, Sun L, Feng G. SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1. Biomedicine & Pharmacotherapy 2019;117:109133. [DOI: 10.1016/j.biopha.2019.109133] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
8 Karar ME, El-Brawany MA. Fully tuned RBF neural network controller for ultrasound hyperthermia cancer tumour therapy. Network 2018;29:20-36. [PMID: 30404543 DOI: 10.1080/0954898X.2018.1539260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]